Clinical TrialsClinical Trialshttp://www.klhsite.com/klh-clinical-trials/2013-03-26T20:48:22ZSquarespaceNCT01644968http://www.klhsite.com/klh-clinical-trials/nct01644968.htmlpreyes admin22012-07-17T16:49:00Z2012-07-17T16:49:00ZPhase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Conditions: Advanced Cancer
Sponsors: Providence Health & Services
Phase: I 

]]>NCT01552681http://www.klhsite.com/klh-clinical-trials/nct01552681.htmlpreyes admin22012-03-09T23:55:00Z2012-03-09T23:55:00ZBaminercept in Sjögren's Syndrome

Conditions: Sjögren's Syndrome
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase: II

]]>NCT01516307http://www.klhsite.com/klh-clinical-trials/nct01516307.htmljensen admin22012-01-19T22:56:00Z2012-01-19T22:56:00ZTrial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

Conditions: Metastatic Breast Cancer
Sponsors: Optimer Biotechnology, Inc.
Phase II

]]>NCT01509391http://www.klhsite.com/klh-clinical-trials/nct01509391.htmljensen admin22012-01-09T22:59:00Z2012-01-09T22:59:00ZKeyhole Limpet Hemocyanin in Chronic Hepatitis C (IM1)

Conditions: Chronic Hepatitis C, Liver Cirrhosis
Sponsors: Medical University of Graz
Phase n/a

]]>2011-004394-90http://www.klhsite.com/klh-clinical-trials/2011-004394-90.htmljensen admin22012-01-09T18:37:00Z2012-01-09T18:37:00Z Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - IM1

Conditions: Chronic Hepatitis C, Liver Cirrhosis
Sponsors: Medical University of Graz
Phase n/a

]]>NCT01498328http://www.klhsite.com/klh-clinical-trials/nct01498328.htmljensen admin22011-12-21T22:54:00Z2011-12-21T22:54:00ZA Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma (ReACT)

Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase II

]]>NCT01489956http://www.klhsite.com/klh-clinical-trials/nct01489956.htmljensen admin22011-12-01T22:51:00Z2011-12-01T22:51:00ZA Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) 
Phase 0 

]]>NCT01480479http://www.klhsite.com/klh-clinical-trials/nct01480479.htmljensen admin22011-11-21T22:57:00Z2011-11-21T22:57:00ZPhase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)

Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase III

]]>NCT01456104http://www.klhsite.com/klh-clinical-trials/nct01456104.htmljensen admin22011-10-18T23:57:00Z2011-10-18T23:57:00ZImmune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma

Conditions: Melanoma
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase I

Source: Clin Cancer Res April 1, 2011 17; 1984 (http://clincancerres.aacrjournals.org/content/17/7/1984.long)

]]>NCT01426828http://www.klhsite.com/klh-clinical-trials/nct01426828.htmlAdministrator2011-08-30T22:15:00Z2011-08-30T22:15:00ZId-KLH Vaccine + T Cells

Conditions: Multiple Myeloma
Sponsors: Abramson Cancer Center of the University of Pennsylvania
Phase II

]]>